Amrutanjan Health [AMRUTANJAN] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Amrutanjan Health Care Ltd.

NSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Amrutanjan Health Care Ltd. wins in 14 metrics, Sun Pharma Advanced Research Company Ltd. wins in 4 metrics, with 0 ties. Amrutanjan Health Care Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Amrutanjan Health Care Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 29.33 -13.65 Amrutanjan Health Care Ltd.
Price-to-Book Ratio 4.87 -13.55 Amrutanjan Health Care Ltd.
Debt-to-Equity Ratio 0.57 -1.21 Amrutanjan Health Care Ltd.
PEG Ratio 27.90 -11.15 Amrutanjan Health Care Ltd.
EV/EBITDA 21.29 -22.27 Amrutanjan Health Care Ltd.
Profit Margin (TTM) 11.65% -53.22% Amrutanjan Health Care Ltd.
Operating Margin (TTM) 16.69% -700.71% Amrutanjan Health Care Ltd.
EBITDA Margin (TTM) 16.69% N/A N/A
Return on Equity 15.56% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 12.06% -102.08% Amrutanjan Health Care Ltd.
Free Cash Flow (TTM) $153.46M $-3.71B Amrutanjan Health Care Ltd.
Dividend Yield 0.88% N/A N/A
1-Year Return -19.81% 34.88% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 3.41 87.98 Amrutanjan Health Care Ltd.
Enterprise Value $14.61B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 2.99 95.73 Amrutanjan Health Care Ltd.
Gross Profit Margin (TTM) 54.77% -59.53% Amrutanjan Health Care Ltd.
Revenue per Share (TTM) $169 $2 Amrutanjan Health Care Ltd.
Earnings per Share (Diluted) $19.66 $-8.25 Amrutanjan Health Care Ltd.
Beta (Stock Volatility) 0.34 0.19 Sun Pharma Advanced Research Company Ltd.

Amrutanjan Health Care Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

AMRUTANJAN
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Amrutanjan Health Care Ltd.-0.55%-0.41%-0.03%5.67%-18.34%-16.87%
Sun Pharma Advanced Research Company Ltd.2.36%12.49%39.95%100.62%67.89%69.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Amrutanjan Health Care Ltd.-19.81%-12.93%-17.97%178.68%639.26%1,105.32%
Sun Pharma Advanced Research Company Ltd.34.88%14.54%-3.55%-20.47%148.26%-23.02%

Performance & Financial Health Analysis: Amrutanjan Health Care Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricAMRUTANJANSPARC
Market Information
Market Cap i₹16.66B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i33,3232,401,062
90 Day Avg. Volume i31,7662,083,443
Last Close₹554.65₹229.03
52 Week Range₹486.00 - ₹790.95₹108.00 - ₹248.75
% from 52W High-29.88%-7.93%
All-Time High₹1,024.55 (Nov 08, 2021)₹875.00 (Apr 24, 2006)
% from All-Time High-45.86%-73.83%
Growth Metrics
Quarterly Revenue Growth0.15%-0.43%
Quarterly Earnings Growth0.01%-0.43%
Financial Health
Profit Margin (TTM) i0.12%-0.53%
Operating Margin (TTM) i0.17%-7.01%
Return on Equity (TTM) i0.16%1.58%
Debt to Equity (MRQ) i0.57-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹118.34₹-10.63
Cash per Share (MRQ)₹71.78₹0.03
Operating Cash Flow (TTM) i₹482.07M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹508.35M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i0.88%N/A
Last 12-Month Dividend i₹5.60N/A

Valuation & Enterprise Metrics Analysis: Amrutanjan Health Care Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricAMRUTANJAN (Apr 26, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i29.33-13.65
Forward P/E iN/A2.60
PEG Ratio i27.90-11.15
Price to Sales (TTM) i3.4187.98
Price to Book (MRQ) i4.87-13.55
Market Capitalization
Market Capitalization i₹16.66B₹46.75B
Enterprise Value i₹14.61B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i2.9995.73
Enterprise to EBITDA i21.29-22.27
Risk & Other Metrics
Beta i0.340.19
Book Value per Share (MRQ) i₹118.34₹-10.63

Financial Statements Comparison: Amrutanjan Health Care Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAMRUTANJAN (2025)SPARC (2025)
Revenue/Sales i4.51B717.66M
Cost of Goods Sold i2.23B1.10B
COGS % of Revenue i49.5%153.2%
Gross Profit i2.27B-381.94M
Gross Margin i50.5%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i535.73M-3.34B
Operating Margin i11.9%-465.5%
EBITDA i760.84M-3.23B
EBITDA Margin i16.9%-450.0%
Pre-Tax Income i691.34M-3.43B
Pre-Tax Income % of Revenue i15.3%-477.6%
Income Tax i182.99M-2.72M
Income Tax % of Revenue i4.1%-0.4%
Net Income (Profit) i508.35M-3.43B
Profit Margin i11.3%-477.3%

Balance Sheet & Liquidity Metrics

MetricAMRUTANJAN (2025)SPARC (2025)
Cash & Equivalents i803.85M19.64M
Total Current Assets i2.91B261.97M
Total Current Assets % of Revenue i64.5%36.5%
Total Current Liabilities i845.83M3.74B
Total Current Liabilities % of Revenue i18.8%521.5%
Long-Term Debt i16.76M1.07B
Long-Term Debt % of Revenue i0.4%149.0%
Total Shareholders Equity i3.27B-2.17B
Retained Earnings i2.73B-23.22B
Retained Earnings % of Revenue i60.6%-3,235.0%
Property, Plant & Equipment i41.91M178.02M

Cash Flow Statement Comparison

MetricAMRUTANJAN (2025)SPARC (2025)
Operating Cash Flow i482.07M-3.48B
Operating Cash Flow % of Revenue i10.7%-485.5%
Capital Expenditures i-355.53M-97.45M
Free Cash Flow i153.46M-3.71B
FCF Margin i3.4%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase i0N/A

Short Interest & Institutional Ownership Analysis

MetricAMRUTANJANSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i28.90M324.52M
Float Shares i13.35M91.32M
% Held by Insiders i53.73%72.96%
% Held by Institutions i12.69%2.56%
% Held by Public i33.58%24.48%

Dividend Analysis & Yield Comparison: Amrutanjan Health Care Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricAMRUTANJANSPARC
Last 12-Month Dividend i₹5.60N/A
Last 12-Month Dividend Yield i0.88%N/A
3-Year Avg Annual Dividend i₹4.93N/A
3-Year Avg Dividend Yield i0.21%N/A
3-Year Total Dividends i₹14.80N/A
Ex-Dividend DateFeb 06, 2026N/A